The development of collaborative network ties and configurations in the commercial biotechnology field is examined, in order to demonstrate how patterns and the logic of interaction and attachment emerge, take root, and shift over time. The ties between biotechnology firms, public research...

In this chapter, we make the argument that science-based firms in the life sciences are expected to actively expand the volume and scope of collaborations, and broaden the kinds of partners with whom they collaborate, as they grow larger, older, and become successful. We base our arguments on a...